IBDEI1D8 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24486,2)
 ;;=^304352
 ;;^UTILITY(U,$J,358.3,24487,0)
 ;;=682.9^^159^1576^2
 ;;^UTILITY(U,$J,358.3,24487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24487,1,3,0)
 ;;=3^682.9
 ;;^UTILITY(U,$J,358.3,24487,1,4,0)
 ;;=4^Cellulitis Unspec
 ;;^UTILITY(U,$J,358.3,24487,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,24488,0)
 ;;=692.9^^159^1576^3
 ;;^UTILITY(U,$J,358.3,24488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24488,1,3,0)
 ;;=3^692.9
 ;;^UTILITY(U,$J,358.3,24488,1,4,0)
 ;;=4^Dermatitis
 ;;^UTILITY(U,$J,358.3,24488,2)
 ;;=^27800
 ;;^UTILITY(U,$J,358.3,24489,0)
 ;;=110.1^^159^1576^4
 ;;^UTILITY(U,$J,358.3,24489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24489,1,3,0)
 ;;=3^110.1
 ;;^UTILITY(U,$J,358.3,24489,1,4,0)
 ;;=4^Dermatophytosis Of Nail
 ;;^UTILITY(U,$J,358.3,24489,2)
 ;;=^33173
 ;;^UTILITY(U,$J,358.3,24490,0)
 ;;=782.1^^159^1576^7
 ;;^UTILITY(U,$J,358.3,24490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24490,1,3,0)
 ;;=3^782.1
 ;;^UTILITY(U,$J,358.3,24490,1,4,0)
 ;;=4^Rash, Nonspecif Skin Eruption
 ;;^UTILITY(U,$J,358.3,24490,2)
 ;;=^102948
 ;;^UTILITY(U,$J,358.3,24491,0)
 ;;=707.10^^159^1576^5
 ;;^UTILITY(U,$J,358.3,24491,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24491,1,3,0)
 ;;=3^707.10
 ;;^UTILITY(U,$J,358.3,24491,1,4,0)
 ;;=4^Leg Ulcer, lower limb, chronic
 ;;^UTILITY(U,$J,358.3,24491,2)
 ;;=^322142
 ;;^UTILITY(U,$J,358.3,24492,0)
 ;;=702.0^^159^1576^1
 ;;^UTILITY(U,$J,358.3,24492,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24492,1,3,0)
 ;;=3^702.0
 ;;^UTILITY(U,$J,358.3,24492,1,4,0)
 ;;=4^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,24492,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,24493,0)
 ;;=696.1^^159^1576^6
 ;;^UTILITY(U,$J,358.3,24493,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24493,1,3,0)
 ;;=3^696.1
 ;;^UTILITY(U,$J,358.3,24493,1,4,0)
 ;;=4^Psoriasis
 ;;^UTILITY(U,$J,358.3,24493,2)
 ;;=^87816
 ;;^UTILITY(U,$J,358.3,24494,0)
 ;;=795.00^^159^1577^2
 ;;^UTILITY(U,$J,358.3,24494,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24494,1,3,0)
 ;;=3^795.00
 ;;^UTILITY(U,$J,358.3,24494,1,4,0)
 ;;=4^Abnormal Pap
 ;;^UTILITY(U,$J,358.3,24494,2)
 ;;=^328609
 ;;^UTILITY(U,$J,358.3,24495,0)
 ;;=V25.09^^159^1577^16
 ;;^UTILITY(U,$J,358.3,24495,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24495,1,3,0)
 ;;=3^V25.09
 ;;^UTILITY(U,$J,358.3,24495,1,4,0)
 ;;=4^Contraceptive Mgmt (1St Visit)
 ;;^UTILITY(U,$J,358.3,24495,2)
 ;;=^87608
 ;;^UTILITY(U,$J,358.3,24496,0)
 ;;=V25.8^^159^1577^17
 ;;^UTILITY(U,$J,358.3,24496,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24496,1,3,0)
 ;;=3^V25.8
 ;;^UTILITY(U,$J,358.3,24496,1,4,0)
 ;;=4^Contraceptive Mgmt (F/U Visit)
 ;;^UTILITY(U,$J,358.3,24496,2)
 ;;=^295353
 ;;^UTILITY(U,$J,358.3,24497,0)
 ;;=626.8^^159^1577^18
 ;;^UTILITY(U,$J,358.3,24497,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24497,1,3,0)
 ;;=3^626.8
 ;;^UTILITY(U,$J,358.3,24497,1,4,0)
 ;;=4^Dysfunctional Bleeding
 ;;^UTILITY(U,$J,358.3,24497,2)
 ;;=^87521
 ;;^UTILITY(U,$J,358.3,24498,0)
 ;;=628.9^^159^1577^25
 ;;^UTILITY(U,$J,358.3,24498,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24498,1,3,0)
 ;;=3^628.9
 ;;^UTILITY(U,$J,358.3,24498,1,4,0)
 ;;=4^Female Infertility Nos
 ;;^UTILITY(U,$J,358.3,24498,2)
 ;;=^62820
 ;;^UTILITY(U,$J,358.3,24499,0)
 ;;=610.1^^159^1577^26
 ;;^UTILITY(U,$J,358.3,24499,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24499,1,3,0)
 ;;=3^610.1
 ;;^UTILITY(U,$J,358.3,24499,1,4,0)
 ;;=4^Fibrocystic Breast
 ;;^UTILITY(U,$J,358.3,24499,2)
 ;;=^46167
 ;;^UTILITY(U,$J,358.3,24500,0)
 ;;=V10.3^^159^1577^29
 ;;^UTILITY(U,$J,358.3,24500,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24500,1,3,0)
 ;;=3^V10.3
